Skip to main content
. 2022 Sep 21;13:1005790. doi: 10.3389/fimmu.2022.1005790

Figure 5.

Figure 5

The MFI of pre-transplant DSA directed against HLA class I and II show a different impact on kidney transplant outcome. Cumulative incidence of ABMR (A) and death-censored graft survival (B) in the DSA I, DSA II, DSA I+II groups with regard to cumulative DSA MFI value. Cumulative incidence of ABMR (C) and death-censored graft survival (D) in the DSA I and DSA II groups in patients with a cumulative MFI of <1k. Cumulative incidence of ABMR (E) and death-censored graft survival (F) of patients with only DSA I stratified into groups based on cumulative MFI of <1k, 1k-2k, and >2k. Log-rank test was used to test p value of the Kaplan-Meier survival curves for (A–F).